Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GenetecTSE:4492 +0.76%77 Receivables Turnover is 3.00 as of Mar. 2026. GuruFocus rates TSE:4492 with a GF Score™ of 77/100 and a GF Value™ of 円765.08 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 2,784 Software companies, Genetec ranks worse than 52.62% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Genetec's Revenue for the
six
months ended in Mar. 2026 was 円5,873 Mil. Genetec's average Accounts Receivable for the
six
months ended in Mar. 2026 was 円1,961 Mil.
Hence, Genetec's Receivables Turnover for the
six
months ended in Mar. 2026 was 3.00.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Genetec Receivables Turnover Related Terms
Genetec Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Genetec's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4492 vs QH, SHOP, UBER: Receivables Turnover Comparison
For the Software - Application subindustry, Genetec's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genetec Receivables Turnover vs Software Industry
For the Software industry and Technology sector, Genetec's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Genetec's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genetec (TSE:4492) has a Receivables Turnover of 3.00 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Genetec and its competitors. According to the industry distribution chart, Genetec ranks #1465 out of 2784 companies in the Software industry, placing it in the top 52.6%.
Is Genetec's Receivables Turnover too high?
Genetec's current Receivables Turnover is 3.00. The Software industry median Receivables Turnover is 5.78. Genetec's value of 3.00 is 48.1% below this industry median. Based on the distribution chart, Genetec ranks #1465 out of 2784 companies in the Software industry, which is below the industry midpoint. Overall, Genetec has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genetec's Receivables Turnover compare to QH and SHOP?
According to the Software industry distribution chart, Genetec ranks #1465 out of 2784 companies for Receivables Turnover. This places Genetec in the lower half of its industry. The industry median Receivables Turnover is 5.78. Genetec's value of 3.00 is 48.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Software company?
The median Receivables Turnover among Software companies is 5.78, based on 2,784 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genetec's current Receivables Turnover of 3.00 is 48.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Genetec and its competitors. For the Software industry, the median Receivables Turnover is 5.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genetec's current Receivables Turnover is 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genetec stock overvalued right now?
Based on GuruFocus' analysis, Genetec (TSE:4492) is currently considered Significantly Undervalued. The stock's GF Value™ is 円765.08, compared to a current price of 円397.00 — trading 48.1% below its estimated fair value. The current Receivables Turnover is 3.00 and 48.1% below the Software industry median of 5.78. Genetec's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Genetec (TSE:4492), the current Receivables Turnover is 3.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genetec (TSE:4492) Overvalued in 2026?
Based on GuruFocus' analysis, Genetec stock appears to be undervalued.
The current stock price of 円397.00 is trading 48.1% below its estimated GF Value™ of 円765.08.
GuruFocus considers Genetec to be Significantly Undervalued.
Key valuation signals for TSE:4492:
Receivables Turnover: 3.00
GF Value™: 円765.08 vs. price of 円397.00 (48.1% below fair value)
Industry Position: 48.1% below the Software median (#1465 of 2784)
No single metric tells the full story. See the TSE:4492 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genetec Corp is engaged in the provision of system development, engineering, and IOT/cloud solutions. Its services include software development, hardware development, engineering solutions, Mastercam, Robomaster, flexisim, IoT/M2M business, surve-I, Coco Dayo, and web integration.
77GF Score
Get the complete analysis for TSE:4492
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4492 has been successfully added to your 
